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ABSTRACT
On 21 May 1981 the WHO International Code of 
Marketing Breast Milk Substitutes (hereafter referred 
to as the Code) was passed by 118 votes to 1, the US 
casting the sole negative vote. The Code arose out 
of concern that the dramatic increase in mortality, 
malnutrition and diarrhoea in very young infants in 
the developing world was associated with aggressive 
marketing of formula. The Code prohibited any 
advertising of baby formula, bottles or teats and gifts 
to mothers or ‘bribery’ of health workers. Despite 
successes, it has been weakened over the years by 
the seemingly inexhaustible resources of the global 
pharmaceutical industry. This article reviews the long 
and tortuous history of the Code through the Convention 
on the Rights of the Child, the HIV pandemic and the rare 
instances when substitute feeding is clearly essential. 
Currently, suboptimal breastfeeding is associated with 
over a million deaths each year and 10% of the global 
disease burden in children. All health workers need to 
recognise inappropriate advertising of formula, to report 
violations of the Code and to support efforts to promote 
breastfeeding: the most effective way of preventing 
child mortality throughout the world.
INTRODUCTION
In the 19th century breastfeeding was almost uni-
versal; however, as Borden developed condensed 
milk in 1856 and Nestlé produced ‘Farine Lactée’ 
in 1867, substitute feeding became feasible.1 Over 
the next 100 years, breastfeeding rates declined 
as women entered the workforce and formula 
companies began widespread advertising cam-
paigns.2 In 1944, 88% of Swedish mothers were 
breastfeeding their infants at 2 months of age; by 
1970 the rate had declined to 30%.3 During the 
1970s and 1980s breastfeeding rates began to rise 
in the industrialised world, particularly among 
older, more educated mothers.2–4 Formula compa-
nies responded by vigorously seeking new mar-
k e ts  in  th e  d e v e l o p in g  w o r l d . 5 Th e y  g a v e  g i fts  
to health workers and used saleswomen dressed 
as ‘nurses’ to provide donations of formula and 
a d v i c e  t o  m o t h e r s .  P o v e r t y ,  i l l i t e r a c y  a n d  p o o r  
sanitation often led to improper formula prepara-
tion. Mortality in very young infants from mal-
nutrition, diarrhoea and pneumonia—virtually 
unknown previously—increased dramatically.5–8
In resource-poor countries doctors, nurses, 
health workers and missionaries became increas-
ingly alarmed at this aggressive marketing and 
rising infant mortality.5–8 Table 1 lists the events 
leading to the passage of the WHO International 
Code of Marketing Breast milk Substitutes (here-
after referred to as the Code).9
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Dr Cicely Williams (1893–1992), medical ofﬁ  cer 
in the British Colonial Service (1929–1948), was 
the ﬁ  rst doctor to decry the promotion of breast 
milk substitutes.10 She maintained that, ‘anyone 
w h o ,  i gn o r an tl y  o r  li gh tl y ,  ca u s e s  a  b a b y  t o  b e  
fed unsuitable milk, may be guilty of that child’s 
death’.10 Eventually, 35 years later the tide ﬁ  nally 
turned with the publication of The Baby Killer by 
War on Want in the UK.11 It was translated into 
German with the provocative title of Nestlé Kills 
Babies.12 Nestlé successfully sued for libel and the 
authors were required to pay a minimal ﬁ  ne. The 
judge emphasised that the verdict was not exculpa-
tory and warned Nestlé to reconsider its marketing 
practices to avoid its products becoming ‘lethally 
dangerous’.12 A very successful worldwide boycott 
of Nestlé products (1977–1984) followed.6 13
In 1978, Edward M Kennedy, chairman of 
the USA Senate Subcommittee on Health and 
Scientiﬁ  c Research, held a hearing on the promo-
tion and use of infant formula in developing coun-
tries.5 He asked, ‘Can a product which requires 
clean water, good sanitation, adequate family 
income and a literate parent to follow printed 
instructions be properly and safely used in areas 
where water is contaminated, sewage runs in the 
streets, poverty is severe and illiteracy high?’
The following year WHO and the United 
Nations Children’s Fund (UNICEF) convened a 
meeting of 150 participants that included repre-
sentatives from national governments, UN agen-
cies, non-governmental organisations, the infant 
food industry and experts on infant feeding.6 
Over the next 2 years they drafted a new code to 
restrict advertising (table 2), which was adopted 
by the World Health Assembly on 21 May 19819 
with 118 votes, three abstentions and one nega-
tive vote (the USA).13
Within 3 years of the Code’s passage, 130 coun-
tries had passed legislation or formulated poli-
cies to restrict advertising.14 Even earlier, in 1977, 
Papua New Guinea had made formula, bottles or 
teats available only by prescription.15 However, 
despite further World Health Assembly resolu-
tions (1986–2010) and the Innocenti declarations 
(1990 and 2005)16 protecting, promoting and sup-
porting breastfeeding, the pharmaceutical indus-
try has continued to undermine such efforts.17–23 
As Coutsoudis et al24 have pointed out, ‘voracious 
global marketing by the formula-milk industry 
over the past 60 years has …dislodged breastfeed-
ing as a viable and desirable strategy for infant 
feeding’. The fact that annual sales of breast milk 
substitutes exceed US$31 billion (£20 billion; €24 
billion)25 gives the industry little incentive to 
restrict advertising.
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Reporting violations
Four major non-governmental organisations document and 
publish violations of the Code: in the UK, the Baby Milk Action 
and the Inter-Agency Group on Breastfeeding Monitoring; in 
Canada, the Infant Feeding Action Coalition (INFACT); and 
in Malaysia, the International Baby Food Action Network 
(IBFAN), the largest with 200 groups in 95 countries.25 In their 
2011 report, State of the Code by Country, IBFAN lists 67 devel-
oping countries (including India, Pakistan, Uganda and Ghana) 
that have passed laws including all or many of the provisions 
of the Code. In Europe, however, only six countries (Norway, 
Serbia, Luxembourg, Albania, Azerbaijan and Georgia) have 
passed such laws.33 A total of 14 countries, including the USA, 
have taken virtually no legal action.33 IBFAN publishes a list of 
violations every 3 years. However, for penalties to be effective, 
they must be sufﬁ  cient, consistent and enforced.34 A single inter-
national agency that is transparent and sustainable is urgently 
needed.34 The importance of such an agency is underscored by 
the global estimate that suboptimal breastfeeding is responsible 
for 13% of child mortality and 10% of child disease.35 36
MORBIDITY AND MORTALITY
Developing countries
Numerous studies have documented the increase in morbidity 
and mortality in developing countries from breast milk substi-
tutes.35–41 Lamberti and associates,41 in a recent meta-analysis 
of 18 studies from the developing world, compared breast milk 
substitutes with exclusive or predominant breastfeeding. The 
relative risk of dying from diarrhoea during the ﬁ  rst 5 months 
of life was 10.52 (95% CI 2.79 to 39.6); from 6 to 12 months it 
was still 2.18 (95% CI 1.14 to 4.16). One of the highest death 
rates was seen in Pakistan, where the RR of dying from an 
infectious disease in the ﬁ  rst month was 21.3 (95% CI 7.9 
to 57.7).37 40 Early initiation of breastfeeding is critical. In a 
Ghanaian study, neonatal mortality in babies fed after the ﬁ  rst 
24 h was over twice that of those fed within the ﬁ  rst hour 
(adjusted OR 2.88, 95% CI 1.87 to 4.42).38
Industrialised countries
Two recent reviews2 42 h a v e  s u mm a r i s e d  s t u d i e s  f r o m  th e  
industrialised world where breast milk substitutes have 
VIOLATIONS OF THE CODE
In 2010, 500 violations were documented in 46 countries.25 
Figure 1 illustrates a billboard in Asia in violation of the Code. 
This type of widespread marketing results in mothers’ rec-
ognising certain brands and believing their children will be 
healthier with formula.26 27
Developing countries
Reports of violations are numerous.17–23 In 1998 a study of 
3442 mothers and health workers from Dhaka, Durban, 
Bangkok and Warsaw documented gifts of formula and infor-
mation violating the Code.17 In a 2003 survey of 186 health-
care providers in 43 health facilities in Togo and Burkina 
Faso, 80% had never heard of the Code.18 In 2004 a survey of 
850 mothers and 125 health workers in Uganda cited numer-
ous violations.19 In 2008, 70% of 427 health professionals 
in Pakistan were unaware of their own breastfeeding laws 
and 80% unaware of the Code; 12% had received sponsor-
ship from pharmaceutical companies for training sessions or 
attendance at conferences.20
Sales of formula are increased when regulations are weak.21 
In 2004 the Supreme Court of the Philippines issued a 
restraining order preventing introduction of the Revised Rules 
and Regulations of the Milk Code in response to intense lobby-
ing by the pharmaceutical industry,21–23 and consequently 
formula use increased.21 Although the restraining order was 
lifted in 2007, the regulations had been weakened to suit the 
industry.21–23 In contrast, in India where advertising is strictly 
controlled by the Infant Milk Substitutes Act,28 exclusive 
breastfeeding at 4–5 months of age is 46% almost three times 
higher than that of the Philippines.21 29
Industrialised Countries
Many companies still provide free meals, research grants and 
ﬁ  nancial support for conferences to doctors.30 Marketing is 
more subtle than in developing countries. In countries such as 
the UK and Australia, where advertising baby formula is pro-
hibited, they circumvent regulations by marketing follow-on 
formulas that they maintain are not a breast milk substitute 
but a weaning milk,14 25 31 a distinction many mothers do not 
understand.31 In the UK, where the rate of exclusive breastfeed-
ing (7% at 4 months)2 is one of the lowest in the world, compa-
nies spend 10 times more on advertising than the Department 
of Health spends on promoting breastfeeding.32 In Norway, by 
contrast, the rate is 64% at 4 months and advertising is strictly 
controlled.2 33 Interestingly, 20% of mothers in the UK who 
were weaning their babies at 4–6 months of age thought for-
mula was better and more nutritious than breast milk.4
Table 1  Events leading to the WHO Code
Year Event
1939 Lecture, Singapore Rotary club: Milk and Murder by Cicely Williams.10
1972 Article: commerciogenic malnutrition by Jelliffe.8
1974 Book: The Baby Killer by Muller.11
1975 Lawsuit by Nestlé against Swiss AgDW for Nestlé kills Babies*12
1977 International boycott of Nestlé products by INFACT6 13
1978 US Senate: Hearings on Infant Formula. Edward M Kennedy5 
(http://www.waba.org.my/news/senate-hearings-on-formula.pdf)
1979 WHO/UNICEF meeting Infant and young child feeding, Geneva.6
*The German translation of ‘The Baby Killer’.
AgDW, Arbeitsgruppe Dritte Weit (Swiss Third World Action Group); INFACT, 
Infant Formula Action Coalition; UNICEF, United Nations Children’s Fund.
Table 2  Summary of the Articles of the WHO International Code of 
Marketing Breast Milk Substitutes*
No advertising to the public
No free samples or gifts to mothers
No promotion of products in healthcare facilities
No contact of mothers by company representatives
No gifts or samples to health workers
No baby pictures idealising formula
No unsuitable products such as sweetened condensed milk to be promoted for 
babies
Information to health workers to be scientiﬁ  c
All information to be objective and to explain the beneﬁ  ts and superiority of 
breastfeeding
Health professionals to disclose to their institution any fellowships, research 
grants, or conferences provided by baby food manufacturers
Manufacturers and distributors to comply with above even if country has not 
  implemented the Code
Professional groups, non-governmental organisations and individuals to inform 
manufacturers, distributors and governments of activities violating the Code
*The Code covers the marketing of all breast milk substitutes, foods and products 
such as bottles and teats.9
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minimal effect on mortality but signiﬁ  cant short-term and 
long-term effects on morbidity. Failure to breastfeed increases 
the risk of  gastrointestinal disease, acute otitis media and 
acute lower respiratory tract infection in infancy.2 42 In older 
children the rates of leukaemia are greater, as are cholesterol 
levels and hypertension and type 1 or type 2 diabetes.2 42 43
CONVENTION ON THE RIGHTS OF THE CHILD
Article 24 of the Convention on the Rights of the Child 
emphasises the need to diminish infant and child mortality 
and ensure that parents are supported in the knowledge of the 
advantages of breastfeeding.44 Although all but two countries, 
Somalia and the USA, have ratiﬁ  ed the Convention, many have 
not yet drafted legislation on the health and welfare of chil-
dren, and few have statutes supporting the rights of women to 
nurse their infants at their workplace.19 45
MOTHER-TO-CHILD TRANSMISSION OF HIV
In 1985 breast milk was found to transmit HIV and infected 
mothers were advised to use breast milk substitutes.46 Formula 
companies responded by promoting the dangers of breast-
feeding and providing free formula in the developing world.47 
However in resource-poor countries substitute feeding increases 
the risk of dying in the ﬁ  rst 7 months of life.48 49 Some doctors 
insist that free formula can be made ‘safe’ in poor countries.50 
However, supplies may become unavailable, and contamina-
tion and overdilution are frequent problems resulting in diar-
rhoea, malnutrition and increased mortality.19 48 51 53
The WHO Guidelines on HIV and Infant Feeding 201052 recom-
mends exclusive breastfeeding for 6 months with antiretroviral 
treatment for the mother. Substitute feeding is recommended 
if, and only if, it is acceptable, feasible, affordable, sustain-
able and safe.52 In resource-poor countries the introduction of 
these guidelines has not resulted in an increase in the postna-
tal transmission of HIV or mortality by 18 months.49 51 52
APPROPRIATE USE OF FORMULA
In some instances formula feeding is clearly essential: when 
the mother has to take cytotoxic or potentially toxic drugs, or 
is unwilling or unable to breastfeed.54 In addition, mothers of 
preterm infants requiring prolonged hospitalisation can rarely 
produce sufﬁ  cient milk.54 Surprisingly, in the 2005 UK Infant 
Feeding Survey only 13% of mothers who were weaning their 
infants were following the correct instructions for preparation 
of formula.4 Healthcare providers need to be able to understand 
the appropriate use of formula and be available to teach moth-
ers how to prepare it correctly.4 54 In resource-poor countries 
WHO suggests heat-treated donor breast milk for infants less 
than 6 months of age—a complicated alternative.52 Modiﬁ  ed 
animal milk is not advised, but might occasionally be the only 
possible choice.
SUMMARY
The aggressive marketing of breast milk substitutes results in 
increased child morbidity and mortality, especially in resource-
poor countries. The WHO Code was designed to prohibit such 
advertising, but the resources of the formula industry remain 
almost inexhaustible. All health workers need to promote and 
support breastfeeding, know and understand the Code, and 
report violations and thus improve child survival throughout 
the world.
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Figure 1  Billboard in central Vientiane, Laos. (Translation: Bear Brand Formula Milk; Advanced; New development; For everyone; Nestlé Brings 
Good Food, Good Life). Photo courtesy of Bryan Watt, Health Frontiers, Laos.
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